Biora Therapeutics Investor Relations Material
Latest events
Q2 2024
Biora Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biora Therapeutics Inc
Access all reports
Biora Therapeutics Inc. is a biotechnology company focused on developing innovative oral biotherapeutics for the treatment of chronic diseases. The company specializes in creating drug delivery systems that allow for the targeted delivery of therapeutics to the gastrointestinal (GI) tract, aiming to improve treatment outcomes and patient experiences. Biora’s pipeline includes therapies for conditions such as inflammatory bowel disease (IBD) and other GI-related disorders, leveraging its proprietary technology platforms for precision medicine. The company is headquartered in San Diego, California, USA, and its shares are listed on the NASDAQ.
Key slides for Biora Therapeutics Inc
Study Update
Biora Therapeutics Inc
Study Update
Biora Therapeutics Inc
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
BIOR
Country
🇺🇸 United States